Janus kinase inhibitors in atopic dermatitis: an umbrella review of meta-analyses.
Authors
He Q, Xie X, Chen Q, Li W, Song Z, Wang X, Ma X, Zeng J, Guo J
Abstract
Clinicians and healthcare policymakers have been drenched with a deluge of overlapping meta-analyses (MAs), and the necessity for comprehensive and clearly defined evidence of Janus kinase inhibitors (JKIs) in atopic dermatitis (AD) is urgent.
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the IASP Privacy Policy. By closing this banner, you agree to the use of cookies.Agree
